title: Receptor-mediated tobacco toxicity: acceleration of sequential expression of alpha5 and alpha7 nicotinic receptor subunits in oral keratinocytes exposed to cigarette smoke.
abstract: Tobacco products and nicotine alter the cell cycle and lead to squamatization of oral keratinocytes (KCs) and squamous cell carcinoma. Activation of nicotinic acetylcholine receptors (nAChRs) elicits Ca(2+) influx that varies in magnitude between different nAChR subtypes. Normal differentiation of KCs is associated with sequential expression of the nAChR subtypes with increasing Ca(2+) permeability, such as alpha5-containing alpha3 nAChR and alpha7 nAChR. Exposure to environmental tobacco smoke (ETS) or an equivalent concentration of nicotine accelerated by severalfold the alpha5 and alpha7 expression in KCs, which could be abolished by mecamylamine and alpha-bungarotoxin with different efficacies, suggesting the following sequence of autoregulation of the expression of nAChR subtypes: alpha3(beta2/beta4) > alpha3(beta2/beta4)alpha5 > alpha7 > alpha7. This conjecture was corroborated by results of quantitative assays of subunit mRNA and protein levels, using nAChR-specific pharmacologic antagonists and small interfering RNAs. The genomic effects of ETS and nicotine involved the transcription factor GATA-2 that showed a multifold increase in quantity and activity in exposed KCs. Using protein kinase inhibitors and dominant negative and constitutively active constructs, we characterized the principal signaling cascades mediating a switch in the nAChR subtype. Cumulative results indicated that the alpha3(beta2/beta4) to alpha3(beta2/beta4)alpha5 nAChR transition predominantly involved protein kinase C, alpha3(beta2/beta4)alpha5 to alpha7 nAChR transition-Ca(2+)/calmodulin-dependent protein kinase II and p38 MAPK, and alpha7 self-up-regulation-the p38 MAPK/Akt pathway, and JAK-2. These results provide a mechanistic insight into the genomic effects of ETS and nicotine on KCs and characterize signaling pathways mediating autoregulation of stepwise overexpression of nAChR subtypes with increasing Ca(2+) permeability in exposed cells. These observations have salient clinical implications, because a switch in the nAChR subunit composition can bring about a corresponding switch in receptor function, leading to profound pathobiologic effects observed in KCs exposed to tobacco products.
authors.affiliation: Department of Dermatology, University of California, Irvine, C340 Medical Sciences I, Irvine, CA 92697, USA.
authors.forename: Juan
authors.initials: J
authors.lastname: Arredondo
authors.forename: Alexander I
authors.initials: AI
authors.lastname: Chernyavsky
authors.forename: David L
authors.initials: DL
authors.lastname: Jolkovsky
authors.forename: Kent E
authors.initials: KE
authors.lastname: Pinkerton
authors.forename: Sergei A
authors.initials: SA
authors.lastname: Grando
mesh_terms: D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000031:analogs & derivatives / Q000494:pharmacology; D002038:Bungarotoxins / Q000494:pharmacology; D002070:Butadienes / Q000494:pharmacology; D002227:Carbazoles / Q000494:pharmacology; D020916:Conotoxins / Q000494:pharmacology; D004533:Egtazic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D050989:GATA2 Transcription Factor / Q000502:physiology; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D015603:Keratinocytes / Q000187:drug effects / Q000502:physiology*; D009419:Nerve Tissue Proteins / Q000096:biosynthesis / Q000502:physiology*; D009538:Nicotine / Q000494:pharmacology*; D009570:Nitriles / Q000494:pharmacology; D010636:Phenols / Q000494:pharmacology; D011090:Polyenes / Q000494:pharmacology; D053284:Polyunsaturated Alkamides / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D034741:RNA, Small Interfering / Q000494:pharmacology; D011978:Receptors, Nicotinic / Q000096:biosynthesis / Q000502:physiology*; D015398:Signal Transduction; D012907:Smoking / Q000503:physiopathology*; D014028:Tobacco Smoke Pollution / Q000009:adverse effects*; D020032:Tyrphostins / Q000494:pharmacology; D015854:Up-Regulation; D064569:alpha7 Nicotinic Acetylcholine Receptor
chemical_list: D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D002038:Bungarotoxins; D002070:Butadienes; D002227:Carbazoles; D020916:Conotoxins; D004533:Egtazic Acid; D050989:GATA2 Transcription Factor; D007093:Imidazoles; D007211:Indoles; D009419:Nerve Tissue Proteins; D009538:Nicotine; D009570:Nitriles; D010636:Phenols; D011090:Polyenes; D053284:Polyunsaturated Alkamides; D011725:Pyridines; D034741:RNA, Small Interfering; D011978:Receptors, Nicotinic; D014028:Tobacco Smoke Pollution; D020032:Tyrphostins; D064569:alpha7 Nicotinic Acetylcholine Receptor; C447158:CHRNA5 protein, human; C579167:Chrna7 protein, human; C113580:U 0126; C095512:alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide; C081021:Go 6976; C070379:1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester; C063302:KN 62; C054474:manumycin; C489251:5-iodo-3-((3,5-dibromo-4-hydroxyphenyl)methylene)-2-indolinone; C090942:4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole